Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 7150376, 17 pages
https://doi.org/10.1155/2017/7150376
Research Article

Novel Therapeutic Effects of Leonurine On Ischemic Stroke: New Mechanisms of BBB Integrity

1Department of Pharmacology, School of Pharmacy and Institute of Biomedical Science, Fudan University, Shanghai, China
2Department of Pharmacology, School of Pharmacy, Macau University of Science & Technology, Macau

Correspondence should be addressed to Yi-Zhun Zhu; om.ude.tsum@uhzzy

Received 7 January 2017; Revised 10 April 2017; Accepted 16 April 2017; Published 13 June 2017

Academic Editor: Margherita Neri

Copyright © 2017 Qiu-Yan Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. A. Radermacher, K. Wingler, F. Langhauser et al., “Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress,” Antioxidants & Redox Signaling, vol. 18, pp. 1418–1427, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Wang, J. Jia, G. Ao et al., “Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia,” Journal of Neurochemistry, vol. 129, pp. 827–838, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Khan, T. S. Dhammu, H. Sakakima et al., “The inhibitory effect of S-nitrosoglutathione on blood-brain barrier disruption and peroxynitrite formation in a rat model of experimental stroke,” Journal of Neurochemistry, vol. 123, Supplement 2, pp. 86–97, 2012. View at Google Scholar
  4. E. A. Neuwelt, B. Bauer, C. Fahlke et al., “Engaging neuroscience to advance translational research in brain barrier biology,” Nature Reviews. Neuroscience, vol. 12, pp. 169–182, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Shi, L. Zhang, H. Pu et al., “Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury,” Nature Communications, vol. 7, p. 10523, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Shi, X. Wei, Z. Wang et al., “HDAC9 exacerbates endothelial injury in cerebral ischaemia/reperfusion injury,” Journal of Cellular and Molecular Medicine, vol. 20, pp. 1139–1149, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Zhang, S. Fang, C. Wan et al., “Excess salt exacerbates blood-brain barrier disruption via a p38/MAPK/SGK1-dependent pathway in permanent cerebral ischemia,” Scientific Reports, vol. 5, p. 16548, 2015. View at Google Scholar
  8. P. Huang, C. M. Zhou, H. Qin et al., “Cerebralcare granule(R) attenuates blood-brain barrier disruption after middle cerebral artery occlusion in rats,” Experimental Neurology, vol. 237, pp. 453–463, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Knowland, A. Arac, K. J. Sekiguchi et al., “Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke,” Neuron, vol. 82, pp. 603–617, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. M. M. Tenreiro, R. Ferreira, L. Bernardino, and M. A. Brito, “Cellular response of the blood-brain barrier to injury: potential biomarkers and therapeutic targets for brain regeneration,” Neurobiology of Disease, vol. 91, pp. 262–273, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Liu, L. Pan, X. Wang, Q. Gong, and Y. Z. Zhu, “Leonurine protects against tumor necrosis factor-alpha-mediated inflammation in human umbilical vein endothelial cells,” Atherosclerosis, vol. 222, pp. 34–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. X. H. Liu, L. L. Pan, H. Y. Deng et al., “Leonurine (SCM-198) attenuates myocardial fibrotic response via inhibition of NADPH oxidase 4,” Free Radical Biology & Medicine, vol. 54, pp. 93–104, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. K. P. Loh, J. Qi, B. K. Tan, X. H. Liu, B. G. Wei, and Y. Z. Zhu, “Leonurine protects middle cerebral artery occluded rats through antioxidant effect and regulation of mitochondrial function,” Stroke, vol. 41, pp. 2661–2668, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. F. J. Ortega, J. Jolkkonen, N. Mahy, and M. J. Rodriguez, “Glibenclamide enhances neurogenesis and improves long-term functional recovery after transient focal cerebral ischemia,” Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism, vol. 33, pp. 356–364, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Hu, X. Sun, F. Tian, H. Zhang, Q. Liu, and W. Tan, “Neuroprotective effects of Isosteviol sodium injection on acute focal cerebral ischemia in rats,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 1379162, 10 pages, 2016. View at Google Scholar
  16. K. P. Loh, S. H. Huang, B. K. Tan, and Y. Z. Zhu, “Cerebral protection of purified Herba Leonuri extract on middle cerebral artery occluded rats,” Journal of Ethnopharmacology, vol. 125, pp. 337–343, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Fu, Y. Gu, J. Q. Jiang et al., “Calycosin-7-O-beta-D-glucoside regulates nitric oxide/caveolin-1/matrix metalloproteinases pathway and protects blood-brain barrier integrity in experimental cerebral ischemia-reperfusion injury,” Journal of Ethnopharmacology, vol. 155, pp. 692–701, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Li, K. Ragheb, G. Lawler et al., “Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production,” The Journal of Biological Chemistry, vol. 278, pp. 8516–8525, 2003. View at Google Scholar
  19. D. Han, W. Fang, R. Zhang et al., “Clematichinenoside protects blood brain barrier against ischemic stroke superimposed on systemic inflammatory challenges through up-regulating A20,” Brain, Behavior, and Immunity, vol. 51, pp. 56–69, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Li, R. N. Ma, L. H. Li, Y. Z. Qu, and G. D. Gao, “Astragaloside IV reduces cerebral edema post-ischemia/reperfusion correlating the suppression of MMP-9 and AQP4,” European Journal of Pharmacology, vol. 715, pp. 189–195, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Garbuzova-Davis, E. Haller, S. N. Williams et al., “Compromised blood-brain barrier competence in remote brain areas in ischemic stroke rats at the chronic stage,” The Journal of Comparative Neurology, vol. 522, pp. 3120–3137, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Liu, X. Jin, K. J. Liu, and W. Liu, “Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage,” The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, vol. 32, pp. 3044–3057, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Wu, W. Guo, S. Z. Lin et al., “Gp130-mediated STAT3 activation by S-propargyl-cysteine, an endogenous hydrogen sulfide initiator, prevents doxorubicin-induced cardiotoxicity,” Cell Death & Disease, vol. 7, article e2339, 2016. View at Publisher · View at Google Scholar
  24. S. Wu, Y. Yue, H. Tian et al., “Tramiprosate protects neurons against ischemic stroke by disrupting the interaction between PSD95 and nNOS,” Neuropharmacology, vol. 83, pp. 107–117, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. C. M. Zehendner, L. Librizzi, J. Hedrich et al., “Moderate hypoxia followed by reoxygenation results in blood-brain barrier breakdown via oxidative stress-dependent tight-junction protein disruption,” PloS One, vol. 8, article e82823, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. L. L. Pan, X. H. Liu, Y. Q. Shen et al., “Inhibition of NADPH oxidase 4-related signaling by sodium hydrosulfide attenuates myocardial fibrotic response,” International Journal of Cardiology, vol. 168, pp. 3770–3778, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. S. M. Gloor, M. Wachtel, M. F. Bolliger, H. Ishihara, R. Landmann, and K. Frei, “Molecular and cellular permeability control at the blood-brain barrier,” Brain Research. Brain Research Reviews, vol. 36, pp. 258–264, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Amantea, G. Micieli, C. Tassorelli et al., “Rational modulation of the innate immune system for neuroprotection in ischemic stroke,” Frontiers in Neuroscience, vol. 9, p. 147, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Asahi, K. Asahi, J. C. Jung, G. J. del Zoppo, M. E. Fini, and E. H. Lo, “Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94,” Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism, vol. 20, pp. 1681–1689, 2000. View at Google Scholar
  30. E. Dejonckheere, R. E. Vandenbroucke, and C. Libert, “Matrix metalloproteinases as drug targets in ischemia/reperfusion injury,” Drug Discovery Today, vol. 16, pp. 762–778, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. M. He, B. Zhang, X. Wei et al., “HDAC4/5-HMGB1 signalling mediated by NADPH oxidase activity contributes to cerebral ischaemia/reperfusion injury,” Journal of Cellular and Molecular Medicine, vol. 17, pp. 531–542, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Burridge and E. S. Wittchen, “The tension mounts: stress fibers as force-generating mechanotransducers,” The Journal of Cell Biology, vol. 200, pp. 9–19, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Vandenbroucke, D. Mehta, R. Minshall, and A. B. Malik, “Regulation of endothelial junctional permeability,” Annals of the new York Academy of Sciences, vol. 1123, pp. 134–145, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Mehta and A. B. Malik, “Signaling mechanisms regulating endothelial permeability,” Physiological Reviews, vol. 86, pp. 279–367, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. S. M. Stamatovic, P. Shakui, R. F. Keep et al., “Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability,” Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism, vol. 25, pp. 593–606, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Chen, Z. Qi, Y. Luo et al., “Non-pharmaceutical therapies for stroke: mechanisms and clinical implications,” Progress in Neurobiology, vol. 115, pp. 246–269, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Yang, E. Y. Estrada, J. F. Thompson, W. Liu, and G. A. Rosenberg, “Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat,” Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism, vol. 27, pp. 697–709, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. S. E. Lakhan, A. Kirchgessner, D. Tepper, and A. Leonard, “Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke,” Frontiers in Neurology, vol. 4, p. 32, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Rosell, A. Ortega-Aznar, J. Alvarez-Sabin et al., “Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke,” Stroke, vol. 37, pp. 1399–1406, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. G. C. Jickling, D. Liu, B. Stamova et al., “Hemorrhagic transformation after ischemic stroke in animals and humans,” Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism, vol. 34, pp. 185–199, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. P. H. Chan, “Role of oxidants in ischemic brain damage,” Stroke, vol. 27, pp. 1124–1129, 1996. View at Publisher · View at Google Scholar
  42. P. H. Chan, “Reactive oxygen radicals in signaling and damage in the ischemic brain,” Journal of Cerebral Blood Flow and Metabolism, vol. 21, pp. 2–14, 2001. View at Publisher · View at Google Scholar
  43. S. Sciarretta, D. Yee, P. Ammann et al., “Role of NADPH oxidase in the regulation of autophagy in cardiomyocytes,” Clinical Science, vol. 128, pp. 387–403, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. S. P. Gray and K. Jandeleit-Dahm, “The pathobiology of diabetic vascular complications--cardiovascular and kidney disease,” Journal of Molecular Medicine, vol. 92, pp. 441–452, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. B. Lassegue, A. San Martin, and K. K. Griendling, “Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system,” Circulation Research, vol. 110, pp. 1364–1390, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Maejima, J. Kuroda, S. Matsushima, T. Ago, and J. Sadoshima, “Regulation of myocardial growth and death by NADPH oxidase,” Journal of Molecular and Cellular Cardiology, vol. 50, pp. 408–416, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Suzuki, K. Hattori, J. Hamanaka et al., “Pharmacological inhibition of TLR4-NOX4 signal protects against neuronal death in transient focal ischemia,” Scientific Reports, vol. 2, article 896, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Kleinschnitz, H. Grund, K. Wingler et al., “Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration,” PLoS Biology, vol. 8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Manea, L. I. Tanase, M. Raicu, and M. Simionescu, “Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells,” Biochemical and Biophysical Research Communications, vol. 396, pp. 901–907, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Sturrock, B. Cahill, K. Norman et al., “Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells,” American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 290, pp. L661–L673, 2006. View at Google Scholar
  51. I. Diebold, A. Petry, J. Hess, and A. Gorlach, “The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1,” Molecular Biology of the Cell, vol. 21, pp. 2087–2096, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. L. Zhang, O. R. Sheppard, A. M. Shah, and A. C. Brewer, “Positive regulation of the NADPH oxidase NOX4 promoter in vascular smooth muscle cells by E2F,” Free Radical Biology & Medicine, vol. 45, pp. 679–685, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Pendyala, J. Moitra, S. Kalari et al., “Nrf2 regulates hyperoxia-induced Nox4 expression in human lung endothelium: identification of functional antioxidant response elements on the Nox4 promoter,” Free Radical Biology & Medicine, vol. 50, pp. 1749–1759, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. A. E. Pepe, Q. Xiao, A. Zampetaki et al., “Crucial role of nrf3 in smooth muscle cell differentiation from stem cells,” Circulation Research, vol. 106, pp. 870–879, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Manea, L. I. Tanase, M. Raicu, and M. Simionescu, “Jak/STAT signaling pathway regulates nox1 and nox4-based NADPH oxidase in human aortic smooth muscle cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, pp. 105–112, 2010. View at Google Scholar
  56. B. Wang, X. Zhu, Y. Kim et al., “Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage,” Free Radical Biology & Medicine, vol. 52, pp. 928–936, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. H. J. Kim, M. Rowe, M. Ren, J. S. Hong, P. S. Chen, and D. M. Chuang, “Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action,” The Journal of Pharmacology and Experimental Therapeutics, vol. 321, pp. 892–901, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. D. I. Sinn, S. J. Kim, K. Chu et al., “Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation,” Neurobiology of Disease, vol. 26, pp. 464–472, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. R. N. Saha and K. Pahan, “HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis,” Cell Death and Differentiation, vol. 13, pp. 539–550, 2006. View at Google Scholar
  60. A. Fischer, F. Sananbenesi, A. Mungenast, and L. H. Tsai, “Targeting the correct HDAC(s) to treat cognitive disorders,” Trends in Pharmacological Sciences, vol. 31, pp. 605–617, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Chen and C. L. Cepko, “HDAC4 regulates neuronal survival in normal and diseased retinas,” Science, vol. 323, pp. 256–259, 2009. View at Publisher · View at Google Scholar · View at Scopus